Analysts said the stock, which has been hit by worries around the windfall tax on diesel and gasoline exports recently, has priced in most of the negatives and valuations are attractive though a runaway rally is unlikely soon.
Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This